多瑞医药：王庆太、曹晓兵拟通过部分要约收购24.30%股份

Group 1 - The core point of the announcement is that Wang Qingtai and Cao Xiaobing plan to make a partial tender offer to acquire 24.30% of Duorui Pharmaceutical's shares at a price of 32.07 yuan per share [1] - Wang Qingtai intends to acquire 22% of the shares, while Cao Xiaobing plans to acquire 2.30% [1]